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Abstract: Recently, the role of infection of the intervertebral disc (IVD) with Cutibacterium acnes
(C. acnes) as a contributor to disc-related low back pain (LBP) has been discussed. The aim of this study
was to investigate whether and how C. acnes contributes to the inflammatory processes during IVD
disease. The prevalence of C. acnes infection in human IVD tissue was determined by aerobic and
anaerobic culture. Thereafter, primary human IVD cells were infected with a reference and a clinical
C. acnes strain and analyzed for pro-inflammatory markers (gene/protein level). In a subsequent
experiment, the involvement of the Toll-like receptor (TLR) pathway was investigated by co-treatment
with sparstolonin B, a TLR2/4 inhibitor. We detected C. acnes in 10% of IVD biopsies (with either
herniation or degeneration). Stimulating IVD cells with both C. acnes strains strongly and significantly
upregulated expression of Interleukin (IL)-1β, IL-6, IL-8, and inducible nitric oxide synthase (iNOS).
IL-6, cyclooxygenase (COX)-2, and iNOS expression was reduced upon TLR2/4 inhibition in 3 out
of 5 donors, whereby responders and non-responders could not be differentiated by their basal
TLR2 or TLR4 expression levels. We demonstrate that exposure of IVD cells to C. acnes induces
an inflammatory response that may contribute to the development of discogenic LBP by involving
TLR2/4 activation, yet only in a subgroup of patients. Whether the same response will be observed
in vivo and where lower inoculums are present remains to be proven in future studies.
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1. Introduction
Low back pain (LBP) is the primary cause of disability worldwide, with a lifetime prevalence of
>80% [1]. The costs associated with LBP are staggering, with, e.g., 2.9 billion CHF of direct costs in
Switzerland [2] and >100 billion USD of total costs in the United States [3]. Therefore, LBP represents
a massive socio-economic burden. One of the main sources of LBP is the degenerating intervertebral
disc (IVD). While disc degeneration is asymptomatic in the majority of people, a subpopulation
experiences painful disc degeneration (DD), characterized by degeneration and consequent structural
failure of the IVD, in combination with nociception [4]. Another pathological process that is commonly
associated with pain development is disc herniation (DH), i.e., structural damage to the outer area of
the disc (the annulus fibrosus—AF), enabling the inner nucleus pulposus (NP) to extrude through
the damaged fibers. While degeneration of the IVD is a process that is required for DH, it does not
necessarily lead to DH, but may be limited to, e.g., microfissures in the endplate or the AF. In both
cases, inflammatory processes are known to play a crucial role in pain development. The extruded NP
tissue in case of DH has long been known to be inflammatory in nature, with invading immune cells
such as macrophages contributing to the inflammatory behavior [5–7]. However, IVD cells themselves
can also release such pro-inflammatory cytokines [5]. This is specifically relevant in painful DD,
where nociception is strongly associated with innervation as well as with the occurrence of chronic
inflammation within the tissue, with selected pro-inflammatory cytokines (e.g., IL-6) causing direct
nerve irritation [7–9]. Several receptors and pathways seem to be implicated in IVD inflammation,
such as Toll-like receptors (TLRs), which can be activated by so-called damage-associated molecular
patterns (DAMPs)) as well as the NF-kB and MAPK pathways [10–13].
More recently, studies on the role of bacterial infection as a contributor to disc-related LBP
have gained intensive interest. As early as in 2001, Stirling et al. reported that 53% of IVD tissues
derived from micro-discectomy were characterized as infected with gram-positive microorganisms,
with Cutibacterium C. acnes (formerly Propionibacterium acnes) being the dominant bacteria [14].
The ability of C. acnes to infiltrate IVD tissue in case of DH has been delineated extensively and
most studies thus far have been conducted on DH samples/patients [15]. However, microfissures
often preceding DH can already allow for C. acnes infiltration (especially as microfissures also support
neovascularization/ angiogenesis) and thus propagate an immunologic response during DD [7].
However, as C. acnes is one of the most abundant bacteria on human skin [16], it is also a proven
contaminant of human clinical samples, e.g., through contact with the patient’s skin or laboratory
reagents. In fact, a recent study investigated the presence of C. acnes DNA in 20 different sample
types using existing next-generation sequencing data and found it to be present in the majority of
samples, albeit at low concentrations [17]. Consequently, the detection of C. acnes in the IVD led to
an intensive debate on the topic “contamination versus low grade infection”, which was further incited
by Albert et al. in 2008, publishing promising results of antibiotic treatment for patients with LBP (with
Modic changes Type 1, prospective uncontrolled trial, n = 32) [18]. This study was later followed-up by
a double-blind randomized clinical controlled trial (LBP patients with Modic changes Type 1, n = 162),
demonstrating superiority of antibiotic treatment over placebo, with improvements in lumbar pain
and leg pain [19]. Underlining the debate, Braten et al. did not find a beneficial effect of antibiotics
in their study [20]. Nonetheless, as bacteria can produce pathogen-associated molecular patterns
(PAMPs), which in turn can function as TLR activators [21], the association between C. acnes infection
in the IVD and the occurrence of discogenic LBP may be related to the induction of inflammatory
processes within the IVD tissue.
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Therefore, the aim of this study was to investigate whether and how C. acnes contributes to
the inflammatory processes during IVD diseases (DD and DH), with a focus on the potential involvement
of the TLR2/4 pathway.
2. Results
2.1. Prevalence of C. acnes Infection in 30 IVD Biopsies
We assessed 30 IVD biopsies for bacterial growth. The biopsies originated from patients operated
due to DH or DD, and their characteristics are summarized in Table 1. Seven out of 30 biopsies (23.3%)
were culture positive for any bacteria (see Table 1), but only three (10%) were positive for C. acnes
after a prolonged cultivation time (in broth only at day 12). All three cultures became positive after
a prolonged cultivation time using enrichment broth. The biopsies with detection of C. acnes originated
from two patients with DH and from one with DD. C. acnes infection could not be correlated with any
patient/tissue characteristics.
Table 1. Characterization of 30 patients undergoing spinal surgery.
Characterization of Patients n (%)
Age, median (range) 55 (20–78)
Sex, female 12 (40)
Smoker 10 (33)















Annulus fibrosus 6 (20)
Nucleus pulposus 19 (63.3)
Mix 5 (16.7)
Disease
Disc herniation 10 (33.3)
Disc degeneration 20 (66.7)
Positive Culture Result 7 (23.3)
Cutibacterium acnes 3 (10)
Coagulase-negative staphylococci 3 3 (10)
Unknown 4 1 (3.3)
1 Pfirrmann Score = a grading system for disc degeneration on MRI T2-spin-echo weighted images. 2 Modic
changes = a grading system for pathological changes in the bones of the spine (body of the vertebrae and in the end
plate of the neighboring disc). 3 Staphylococcus hominis (n = 1), Staphylococcus saprophyticus (n = 1), Staphylococcus
capitis/Staphylococcus epidermidis (n = 1). 4 Unknown pathogen (unsuccessful identification by MALDI-TOF, DNA
not stored for molecular analysis).
2.2. Changes in IVD Cell Gene Expression upon Exposure to C. acnes
To assess the impact of C. acnes infection on IVD cells, we analyzed the gene expression of different
inflammation markers.
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Cell viability, measured as metabolic activity (MTT assay), was higher than 80% in all three C. acnes
concentrations measured (multiplicities of infection (MOI) 1, 10, and 100). MOI 100 was chosen in
subsequent experiments to achieve the clearest results (the metabolic activity of MOI 100 is shown in
Supplementary Figure S1).
We examined the gene expression of IL-1β, IL-6, IL-8, cyclooxygenase 2 (COX-2), inducible nitric
oxide synthase (iNOS), and human prostaglandin E synthase 2 (PTGES2) in human IVD cells (mixture
of NP and AF cells with different NP/AF ratios depending on the biopsy) infected with C. acnes to
assess the extent of inflammation. Figure 1a shows the differences in gene expression of untreated
cells and infected cells (either with the ATCC C. acnes strain (black) or the clinical C. acnes strain (light
grey)), displayed as logarithmic fold change. Gene expression of all measured markers was highly and
significantly upregulated (all p < 0.034), with the highest increases for IL-8 and iNOS, followed by
IL-1β and IL-6. Mean fold changes were 2069 (ATCC strain (A)) and 695 (clinical strain (C)) for IL-1β,
714 (A) and 208 (C) for IL-6, 30276 (A) and 3677 (C) for IL-8, 140 (A) and 23 (C) for COX-2, 2969 (A)
and 1864 (C) for iNOS, and 139 (A) and 27 (C) for PTGES2. Fold changes varied greatly between
individual donors. Stimulation with C. acnes furthermore induced a moderate upregulation of TLR2
and a minor downregulation of TLR4 (data not shown). Since the ATCC and the clinical strains had
distinct morphologies regarding hemolytic activity and presumably differences in virulence, we were
interested in the comparison of the gene expression levels of both strains. However, no statistical
significance was detected for any of the genes.
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Figure 1. C. acnes-induced changes of pro-inflammatory markers in intervertebral disc (IVD) cells.
The black bars display results obtained with the ATCC C. acnes strain, whereas light grey shows results
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obtained with the clinical strain (n = 4 donors with 2 technical replicates for each donor). (a) Gene
expression of Interleukin (IL)-1β, IL-6, IL-8, cyclooxygenase (COX)-2, inducible nitric oxide synthase
(iNOS), and prostaglandin E synthase 2 (PTGES2). Fold changes (2−∆∆Ct) are indicated on a logarithmic
scale and normalized to the endogenous control glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
as well as the negative control; * p < 0.05. Data represent the mean with standard deviation (SD).
(b) Protein expression of IL-6 and IL-8 in ng/mL. Mean with SD is shown. (c) Correlation of IL-6
between qPCR and ELISA results. (d) Correlation of IL-8 between qPCR and ELISA results. Spearman
correlation coefficients: r = 0.86; p = 0.01.
2.3. Changes in IVD Cell Protein Expression upon Exposure to C. acnes
To confirm the elevated levels of pro-inflammatory cytokines, which were discussed in Section 2.2,
we performed experiments on the protein level by measuring protein concentrations with ELISA.
In this experiment, IL-1β, IL-6, and IL-8 levels were measured. IL-1β levels were below the detection
limit in the control as well as the infected cells, but also had higher Ct values than IL-6 and IL-8 in
qPCR experiments. Figure 1b shows the protein expression levels of IL-6 and IL-8. The IL-6 levels were
0.1 ± 0.1 ng/mL in the untreated control, 20.5 ± 18.7 ng/mL in the cells infected with the ATCC strain,
and 8.3 ± 12.4 ng/mL in the cells infected with the clinical strain. Accordingly, the IL-8 levels were
0.5 ± 0.7 ng/mL in the untreated control, 26.3 ± 22.2 ng/mL in the cells infected with the ATCC strain,
and 11.9 ± 14.8 ng/mL in the cells infected with the clinical strain. Although both cytokines showed
highly increased concentrations in infected cells, these results did not reach statistical significance
due to high fluctuations between individual donors (IL-6 ATCC: p = 0.078; IL-6 clinical: p = 0.17; IL-8
ATCC: p = 0.065; IL-8 clinical: p = 0.127).
The results on gene and protein level correlate by looking at the different donors as shown in
Figure 1c (IL-8) and Figure 1d (IL-6) with a Spearman correlation coefficient of 0.8571 (p = 0.011). qPCR
and ELISA results showed a high correlation, meaning that donors with high fold changes also showed
high concentrations in ELISA experiments.
2.4. Involvement of TLR2/4
Sparstolonin B is a potent TLR2/4 inhibitor, and according to our hypothesis of TLR2/4 involvement
in C. acnes-induced inflammation, cytokine levels should decrease after stimulation with it.
Inhibition of marker genes varied greatly between the different donors. Donors in which
the expression of the different target genes was partially inhibited are defined as responders (n = 3),
whereas donors in which sparstolonin B showed no inhibitory effect are described as non-responders
(n = 2).
Figure 2a shows gene expression of IL-6, IL-8, COX-2, and iNOS after TLR2/4 inhibition in
responders (grey) and non-responders (black) compared to the control without TLR2/4 inhibition.
Mean expression of the responders was 41 ± 7.9% for IL-6, 100 ± 26.2% for IL-8, 49.7 ± 2.6% for
COX-2, and 55.3 ± 2.6% for iNOS. Mean expression of the non-responders was 138.5 ± 20.5% for
IL-6, 211 ± 121% for IL-8, 115.5 ± 2.5% for COX-2, and 163.5 ± 47.5% for iNOS. IL-6, COX-2, and
iNOS expressions were significantly decreased after inhibition of TLR2/4 in the responder cells (IL-6:
p = 0.009; COX-2: p = 0.001; iNOS: p = 0.002), whereas there was no observed inhibition in all the
investigated genes in the non-responders as well as of IL-8 expression in the responders. Furthermore,
we observed a significant difference within responders and non-responders in the expression of COX-2,
with a p-value of p = 0.0002.
Figure 2b displays protein expression levels obtained with ELISA. Expression levels were decreased
more extensively compared to the qPCR results, with significant reductions of IL-6 in the responders
(p = 0.004) and a significant difference between responders and non-responders (p = 0.017). Mean
expression levels were 23.3 ± 7.1% (responders) and 58.5 ± 4.5% (non-responders) for IL-6. For IL-8,
no significances were reached and mean responses were 57.3 ± 22.6% (responders) and 89.0 ± 21.0%
(non-responders).
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3. Discussion
The role of C. acnes infect on in the development of back pain has been an extensive matter of debate
for a while, following publications reporting on a potenti l benefit of a tibiotics treatment in back pain
patients [18,19] as well as studies describing a high prevalence (46%) of C. acnes infection in herniated
IVD tissue [22]. In this study, we only found C. acnes in 10% of human IVD biopsies when culturing the
pathogen in broth only and never on direct agar plating, pointing towards a very low inoculum in IVD
tissue. Interestingly, C. acnes positivity was not only found in DH samples (as previously reported [19]),
but also in a DD sample, indicating that degenerative processes with associated development of, e.g.,
microfissures can serve as an entry point for bacteria. Due to the limited sample number, we could
not determine whether any specific patient or tissue characteristics predispose for C. acnes infection.
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Although care was taken during surgical preparation and biopsy excision, the potential risk of sample
contamination in the pre-analytical phase cannot be ruled out, which would result in a slightly lower
prevalence of C. acnes growth than the stated 10%. Our findings are comparable to the 15.6% recently
reported by Ahmed-Yahia [23]. Using molecular testing following enrichment cultures of 14 days,
Yuan et al. [24] recently described a C. acnes prevalence of 20% (15 out of 76). However, the risk for
false positive results may be increased using molecular methods (which has been commonly used in
past IVD research [25]) compared to positive conventional cultures with subsequent identification of
growing colonies, thus indicating a possible overestimation of the role of C. acnes in IVD pathologies
and back pain.
It has recently been hypothesized that C. acnes infection of the IVD might lead to back pain due
to the induction of inflammatory tissue responses. In support of this theory, we were able to show
strong upregulation of gene expression of IL-1β, IL-6, IL-8, and iNOS following exposure of IVD cells
(isolated from DH and DD biopsies) to a clinical and a laboratory C. acnes strain. This increase could be
confirmed on the protein level in IL-6 and IL-8, with a good correlation to gene expression. Dudli et al.
also demonstrated an increase in IL-1, IL-6, and IL-8 mRNA expression in IVD cells upon co-culture
(MOI 10 and MOI 100), however, at a much lower level (typically < 10 fold); only in 6 out of 10 donors
and without any analysis of the protein level [26]. However, it has to be pointed out that in vitro studies
can only serve as a model system that does not fully represent the human in vivo situation. In fact,
Yuan et al. were able to verify the increased expression of IL-8 in C. acnes positive IVD biopsies, whereas
IL-1β and IL-6 were not significantly different from uninfected controls in this explant study [24].
Despite being a tissue with an extremely low cellularity [27], in vivo ratios of IVD cells to C. acnes are
likely lower than in vitro MOIs. We chose MOI 100 to induce a clear, model-like response in which
the involvement of the TLR pathway could be examined clearly. Therefore, inflammatory IVD cell
responses are probably lower in affected patients than observed in vitro.
A potential bias in the extent of inflammation could be introduced due to the composition of
disc cells (mix of NP and AF or predominant fraction of one type) or invading inflammatory cells
(particularly macrophages) [28]. Despite much research activity, no markers have yet been established
by the research community that conclusively distinguish NP cells from AF cells, although novel
possible candidates are emerging [29]. During DD, the NP tissue undergoes a loss in proteoglycans
with a concomitant shift of Coll-2 to Coll-1, which increases its similarity to AF tissue, making zonal
differentiation challenging [30]. The potentially invading tissue macrophages upon structural failure
of the IVD are well known to have very limited proliferation capacity and their self-renewal capacity is
determined by specific environmental conditions not present in the IVD cell expansion setup used in
this study [31]. However, any remaining tissue macrophages contained in the culture would be fairly
reflective of the in vivo situation.
Following confirmation of the induction of an inflammatory response, we were interested in
identifying the underlying molecular mechanism. We previously showed the relevance of the TLR
pathway in IVD pathologies [32], specifically in IVD inflammation [12,33]. Furthermore, C. acnes
has been shown to activate TLR2 in numerous cell types, such as monocytes [34], human embryonic
kidney (HEK) 293 cells [34], and keratinocytes [35], typically leading to subsequent activation of
the NF-kB pathway. For an extensive summary of the interplay between C. acnes and TLR2 activation
in the context of acne vulgaris, we refer the reader to a recent review article by Zhang et al. [21].
In IVD cells, C. acnes was shown to induce apoptosis via TLR2 activation and subsequent induction of
the c-Jun N-terminal kinase (JNK) pathway [36]. Our own data also demonstrated involvement of
the TLR2/4 pathway in IVD cell inflammation following exposure to C. acnes, but only in a subgroup
of patients (so-called responders). Interestingly, responders did not possess a higher basal mRNA
expression of TLR2 or TLR4 or dissimilar changes in their expression upon C. acnes stimulation than
non-responders, suggesting that other factors or mechanisms must contribute to this disparate response
pattern amongst different donors. However, due to a relatively small sample size, these questions
could not be answered in the present study but will be investigated in future projects focusing on
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genetic mutations. An interesting candidate in that context will be analysis of the role of nucleophosmin
gene mutations, which was earlier shown to distinguish TLR responders and non-responders in human
acute myeloid leukemia cells [37].
In summary, the exposure of IVD cells to C. acnes induced an inflammatory response with elevated
IL-6 and IL-8 expression levels in vitro, which (for IL-6) were mediated by TLR2/4 activation in
a subgroup of patients. While most C. acnes studies focus on DH biopsies/patients, our cell culture
studies showed that C. acnes induced in inflammatory response in cells stemming from both, DD,
and DH. In vivo, microfissures and associated angiogenesis may be sufficient to allow for C. acnes
infiltration [7]. Due to the very low inoculum in IVD tissue, the response rate in vivo is, however,
likely reduced. Nonetheless, this study provided a theoretical molecular link between C. acnes infection
and discogenic back pain through induction of chronic inflammation that can build the basis for
further investigations.
4. Materials and Methods
4.1. Detection of C. acnes in Clinical Samples of IVD Biopsies
Degenerated IVDs were removed by posterior discectomy of patients with DD or DH. To avoid
tissue biopsy contamination during surgery, the following prevention strategies were routinely
performed: (1) skin preparation with povidone iodine/alcohol three times, (2) anti-microbial prophylaxis
with cefuroxime 30 min before skin incision, and (3) tissue removal using unused surgical instruments
and under meticulous avoidance of touching the skin with neither the tissue nor the instruments.
As the prevalence of C. acnes in IVDs has been described to be 13–44% [15], we aimed at a sample
number of at least n = 25.
Biopsies were immediately sent to the research bacterial laboratory of the University Hospital
Zurich where the biopsies were cut into small pieces and homogenized (Polytron PT1200 homogenizer,
Kinematica, Lucerne, Switzerland) for 1 min. On Brain Heart Infusion (BHI) agar (70138, Sigma,
St. Louis, MO, USA), 100 µL of the homogenized liquid were plated for aerobic (three days) and
anaerobic culture (10 days). In addition, the whole biopsy was inoculated in thioglycolate broth
(221196, Becton Dickinson, Franklin Lakes, NJ, USA) to enrich the culture. Thioglycolate medium
was inspected every third day for cloudiness. Subsequently, 100 µL of cloudy liquid were plated onto
aerobic and anaerobic agar plates for microbial growth and further identification. If the thioglycolate
broth culture was negative for 10 days, a final blind subculture on brucella agar (10% sheep blood
agar (Becton Dickinson, Franklin Lakes, NJ, USA) with hemin and vitamin K1 (Sigma, St. Louis, MO,
USA)) was done for another two to three days. All growing colonies were identified by MALDI-TOF
(matrix-assisted laser desorption ionization–time of flight) using a Bruker MALDI Biotyper (Becton
Dickinson, Franklin Lakes, NJ, USA).
4.2. Isolation of IVD Cells and Primary Cell Culture
Mixed IVD tissue was collected from 9 patients undergoing spinal surgery due to DD and
DH (further information is shown in Table 2). Infection experiments where conducted on tissue
from 4 patients, inhibition experiments on tissue from 5 patients. All patients granted written
informed consent and the study was approved by the Ethic Committee Zurich (#EK-16/05 (01/2009) and
#2019-00736 (05/2019)). The tissue was cut into pieces for enzymatic digestion with 0.2% collagenase
NB4 (17454, Serva, Heidelberg, Germany) and 0.3% dispase II (04942078001, Roche, Basel, Switzerland)
for 12–18 h at 37 ◦C. After filtration with a 70 µM cell strainer, the cells were suspended in Dulbecco’s
Modified Eagle’s Medium (DMEM/F12, D8437, Sigma, St. Louis, MO, USA) supplemented with
10% fetal calf serum (FCS, F7524, Sigma, St. Louis, MO, USA) and 1% Antibiotics-Antimycotics
(A/A, 15240062, Gibco, Carlsbad, CA, USA). Sub-cultures up to three passages were used for further
experiments. The IVD cultures contained a mixture of NP and AF cells, with some biopsies being
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predominantly NP, some being predominantly AF and other likely being an even mixture. Cells were
maintained at 37 ◦C with 5% CO2, and media were changed twice a week.
Table 2. Characterization of 9 patients providing biopsies for IVD cultures.
Characterization of Patients n (%)
Age, median (range) 60 (25–74)















Disc herniation 5 (55.6)
Disc degeneration 3 4 (44.4)
1 Pfirrmann Score = a grading system for disc degeneration on MRI T2-spin-echo weighted images. 2 Modic changes
= a grading system for pathological changes in the bones of the spine (body of the vertebrae and in the end plate of
the neighboring disc). 3 Some cases had a concomitant pathology, such as listhesis.
4.3. Bacterial Culture
To observe the impact of their origin, two C. acnes strains were used for the experiments:
the reference strain ATCC 11,827 used for biofilm studies and a clinical strain isolated from a patient with
a spine infection (personal clinical strain collection Y69) [38,39]. The strains were cultured on Brucella
agar (10% sheep blood agar (Becton Dickinson, Franklin Lakes, NJ, USA) with hemin and vitamin K1
(Sigma, St. Louis, MO, USA)) for 72 h under anaerobic conditions at 37 ◦C. For sub-cultivations and
liquid cultures, BHI agar (70138, Sigma, St. Louis, MO, USA) and broth (211059, BD, Franklin Lakes,
NJ, USA) were used.
4.4. Metabolic Activity Assay (MTT)
To assess the influence of co-culturing IVD cells and C. acnes and of treatment with
sparstolonin B (SML1767, Sigma, St. Louis, MO, USA) on metabolic activity, the MTT assay
(3-[4–dimethylthiazol-2-yl]µ-2,5-diphenyl tetrazolium bromide formazan, M2003, Merck, Darmstadt,
Germany) was used. IVD cells were seeded and co-cultured with C. acnes (MOI 1, 10, and 100) with
or without stimulation of different sparstolonin B concentrations (10, 15, 20, 25, 50, and 100 µM).
Extracellular bacteria were killed by incubation for 2 h with penicillin G (0.128 mg/mL, 13752, Merck,
Darmstadt, Germany). The cells were then incubated with MTT in DMEM/F12 (5 mg/mL) for 2 h
at 37 ◦C, 0.04 M HCl (H1758, Sigma, St. Louis, MO, USA) in isopropanol (2-propanol, I9516, Sigma,
St. Louis, MO, USA) was used as a solubilization solution, and the absorbance was measured at 570 nm.
Metabolic activity was calculated relative to the untreated control.
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4.5. Infection of IVD Cells with C. acnes
5 × 105 IVD cells in 3 mL media (approximately 1.7 × 105 cells/mL) were seeded onto 6-well plates
and incubated for 24 h in DMEM/F12 supplied with 10% FCS but without A/A to allow co-cultivation
with C. acnes. The bacteria were grown in liquid culture for 48 h before they were added to the IVD
cells in a 100:1 multiplicity of infection (MOI).
To guarantee an immediate contact between the cells and the bacteria, the plates were centrifuged
at 250× g for 5 min. The cultures were harvested 24 h post infection. The supernatants were sterile
filtered and frozen at −80 ◦C for further ELISA experiments, whereas the pellets were washed three
with Phosphate Buffered Saline (PBS, pH 7.4, 10010-015, Gibco, Carlsbad, CA, USA) to get rid of all the
bacteria. The IVD cells were lysed with Qiagen RNeasy RLT buffer (74106, Qiagen, Hilden, Germany).
4.6. Infection of IVD Cells with C. acnes with TLR2/4 Inhibition
For the inhibition assay, the experiment explained in Section 2.4 was repeated with one difference.
The IVD cells were pre-treated with 25 µM sparstolonin B 1 h prior to infection with bacteria to
inhibit TLR2/4.
4.7. RNA Isolation and Gene Expression Analysis
RNA was isolated with the Qiagen RNeasy Mini Kit (74106, Qiagen, Hilden, Germany) according
to the manufacturer’s instructions. RNA concentration and purity were measured with the NanoDrop
(ND-1000, Thermo Fisher Scientific, Waltham, MA, USA). In a total volume of 60 µL, 0.85–1.7 µg RNA
(depending on concentration) were transcribed to cDNA using the reverse transcription kit (4374966,
Applied Biosystems, Foster City, CA, USA). Gene expression of the target genes shown in Table 3 was
analyzed with qPCR (CFX96 Touch™ Detection System, Biorad, Hercules, CA, USA), using 30 ng of
cDNA/reaction. The Ct values were normalized to the endogenous control glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) and to the untreated cells and displayed as fold change (2−∆∆Ct).
Table 3. TaqMan primers used for qPCR.










Abbreviations: COX-2, cyclooxygenase-2; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; IL, interleukin;
iNOS, inducible nitric oxide synthase; PTGES2, human prostaglandin E synthase 2; TLR, toll-like receptor.
4.8. ELISA
The supernatants, which were collected from the infection and inhibition experiments, were
further used for the protein analysis with ELISA. Levels of Interleukin-6 and IL-8 were tested with
the BD OptEIA human ELISA kits (IL-6 555220, IL-8 555244, BD Biosciences, San Jose, CA, USA)
according to the manufacturer’s instructions. Based on the standard curves, IL-6/-8 concentrations
were calculated.
Human IL-1β was measured using a multiplexed particle-based flow cytometric cytokine
assay [40]. The IL-1β kit was purchased from Biotechne (Oxon, UK). The procedure closely followed
the manufacturer’s instructions. The analysis was conducted using a conventional flow cytometer
(Guava EasyCyte Plus, Millipore, Zug, Switzerland).
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4.9. Statistical Analysis
Data consistency was checked, and data were screened for outliers. Continuous variables were
tested for normality by using Kolmogorov–Smirnov tests. One-sample Wilcoxon Signed Rank tests
(one sided) were used to test whether medians were larger 1. Corresponding paired tests were
tested two sided. All reported tests were two-sided, and p-values < 0.05 were considered statistically
significant. All statistical analyses in this report were performed by use of PASW 21 (IBM SPSS Statistics
for Windows, Version 21.0., Armonk, NY), NCSS 10 Statistical Software (2015), NCSS, LLC. Kaysville,
UT, USA and STATISTICA 13 (Hill, T., and Lewicki, P. Statistics: Methods and Applications. StatSoft,
Tulsa, OK, USA).
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/2227-9059/8/7/186/s1.
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Abbreviations
IVD Intervertebral disc
C. acnes Cutibacterium acnes
LBP Low back pain
TLR Toll-like receptor
IL Interleukin






DAMP Damage-associated molecular pattern
PAMP Pathogen-associated molecular pattern
MOI Multiplicity of infection
PTGES2 Human prostaglandin E synthase 2
JNK c-Jun N-terminal kinase
BHI Brain Heart Infusion
MALDI-TOF Matrix-assisted laser desorption ionization–time of flight
DMEM Dulbecco’s Modified Eagle’s Medium
FCS Fetal calf serum
A/A Antibiotics/antimycotics
MTT 3-[4–dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide formazan
PBS Phosphate Buffered Saline
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